LN Trademark

Trademark Overview


On Thursday, July 15, 2021, a trademark application was filed for LN with the United States Patent and Trademark Office. The USPTO has given the LN trademark a serial number of 90831436. The federal status of this trademark filing is REGISTERED as of Tuesday, March 28, 2023. This trademark is owned by Lunan Pharmaceutical Group Co., Ltd.. The LN trademark is filed in the Chemical Products category with the following description:

Active chemical ingredients for use in the manufacture of pharmaceuticals and pharmaceutical substances for the treatment of anaphylactic reactions, pain, inflammation, cancer, oncological diseases, diabetes, obesity, cancer, cardiovascular and cerebrovascular diseases, colds, cough, influenza, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; active chemical ingredients for use in the manufacture of anti-inflammatory pharmaceutical preparations
ln

General Information


Serial Number90831436
Word MarkLN
Filing DateThursday, July 15, 2021
Status700 - REGISTERED
Status DateTuesday, March 28, 2023
Registration Number7009081
Registration DateTuesday, March 28, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized design of a globe with Chinese lettering inside the parallels and flanked by the letter "L" with an extended underline and the letter "N" on the right.
Transliteration StatementThe non-Latin characters in the mark transliterate to ¿LU¿ and ¿NAN¿. ¿LU¿ means ¿RUDE¿ or ¿RECKLESS¿ and ¿NAN¿ means ¿SOUTH¿ in English.
Goods and ServicesActive chemical ingredients for use in the manufacture of pharmaceuticals and pharmaceutical substances for the treatment of anaphylactic reactions, pain, inflammation, cancer, oncological diseases, diabetes, obesity, cancer, cardiovascular and cerebrovascular diseases, colds, cough, influenza, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; active chemical ingredients for use in the manufacture of anti-inflammatory pharmaceutical preparations

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, September 21, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLunan Pharmaceutical Group Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSHANDONG PROVINCE 276010
CN

Party NameLunan Pharmaceutical Group Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSHANDONG PROVINCE 276010
CN

Party NameLunan Pharmaceutical Group Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSHANDONG PROVINCE 276010
CN

Trademark Events


Event DateEvent Description
Tuesday, March 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 28, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 7, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, December 7, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 7, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, December 7, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, December 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 2, 2022ASSIGNED TO LIE
Friday, October 14, 2022NOTICE OF REVIVAL - E-MAILED
Thursday, October 13, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 13, 2022PETITION TO REVIVE-GRANTED
Thursday, October 13, 2022TEAS PETITION TO REVIVE RECEIVED
Monday, April 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 11, 2022NON-FINAL ACTION E-MAILED
Monday, April 11, 2022NON-FINAL ACTION WRITTEN
Tuesday, April 5, 2022ASSIGNED TO EXAMINER
Wednesday, September 22, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, September 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 19, 2021NEW APPLICATION ENTERED